165 related articles for article (PubMed ID: 8634921)
1. Nitrate tolerance--problems both new and old.
Parker JO
Can J Cardiol; 1996 May; 12 Suppl C():5C-8C. PubMed ID: 8634921
[TBL] [Abstract][Full Text] [Related]
2. Nitrate tolerance--can it be prevented?
Parker JO
Eur Heart J; 1991 May; 12 Suppl A():13-5. PubMed ID: 1874269
[TBL] [Abstract][Full Text] [Related]
3. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
Savonitto S; Motolese M; Agabiti-Rosei E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
[TBL] [Abstract][Full Text] [Related]
4. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
Thadani U
Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
[TBL] [Abstract][Full Text] [Related]
5. Short and long-acting oral nitrates for stable angina pectoris.
Thadani U; Lipicky RJ
Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
[TBL] [Abstract][Full Text] [Related]
6. Nitrate tolerance. How to prevent it or minimize its effect.
Thadani U
Postgrad Med; 1992 Apr; 91(5):307-12, 315-8. PubMed ID: 1561169
[TBL] [Abstract][Full Text] [Related]
7. Nitrate therapy: continuous or pulse dosing.
Thadani U; Whitsett TL
Ration Drug Ther; 1987 Jul; 21(7):1-6. PubMed ID: 3124208
[No Abstract] [Full Text] [Related]
8. Nitrate tolerance.
Parker JO
Am J Cardiol; 1985 Dec; 56(17):28I-31I. PubMed ID: 3934952
[TBL] [Abstract][Full Text] [Related]
9. [Administration of nitroglycerin using transdermal patches].
Kulbertus H
Rev Med Liege; 1997 Nov; 52(11):709-11. PubMed ID: 9480496
[No Abstract] [Full Text] [Related]
10. Nitrate tolerance.
Leier CV
Am Heart J; 1985 Jul; 110(1 Pt 2):224-32. PubMed ID: 3925742
[TBL] [Abstract][Full Text] [Related]
11. Nitrate tolerance. A problem during continuous nitrate administration.
Parker JO
Eur J Clin Pharmacol; 1990; 38 Suppl 1():S21-5. PubMed ID: 2113001
[TBL] [Abstract][Full Text] [Related]
12. Nitrate therapy for stable angina pectoris.
Parker JD; Parker JO
N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470
[No Abstract] [Full Text] [Related]
13. Potential problems with intermittent nitrate therapy.
Parker JD
Can J Cardiol; 1996 May; 12 Suppl C():22C-24C. PubMed ID: 8634920
[TBL] [Abstract][Full Text] [Related]
14. Counterregulatory responses: sustained-release isosorbide-5-mononitrate versus transdermal nitroglycerin.
Parker JD
J Cardiovasc Pharmacol; 1996 Nov; 28(5):631-8. PubMed ID: 8945675
[TBL] [Abstract][Full Text] [Related]
15. [Nitrate tolerance].
Kinoshita M
Kokyu To Junkan; 1988 Jun; 36(6):615-23. PubMed ID: 3146118
[No Abstract] [Full Text] [Related]
16. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
[TBL] [Abstract][Full Text] [Related]
17. [Quality of life and angina pectoris. Comparison of the effects of 2 nitrate derivatives administered discontinuously: transdermal 10 mg nitroglycerine patch (12 hours) and long-acting oral 40 mg isosorbide-5-mononitrate (once a day)].
Marquis P; Le Gal M; Francillon A; André-Fouet X
Ann Cardiol Angeiol (Paris); 2001 Oct; 50(6):340-50. PubMed ID: 12555626
[TBL] [Abstract][Full Text] [Related]
18. [Transdermal forms of nitrates].
Penkov N; Sirakova V
Vutr Boles; 1989; 28(5):12-6. PubMed ID: 2515658
[No Abstract] [Full Text] [Related]
19. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
20. [Therapeutic range of transdermal nitro-patches].
Lazebnik LB
Klin Med (Mosk); 1995; 73(5):47-50. PubMed ID: 8815277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
